Breast Arterial Calcifications May Be Marker for Future Heart Disease
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 11, 2024 -- Breast arterial calcifications (BAC) identified on mammography are associated with the development of both atherosclerotic cardiovascular disease (ASCVD) events and risk factors over 18 years, according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.
Schyler Said, from Drexel University in Philadelphia, and colleagues assessed the longitudinal association between BAC and ASCVD. The analysis included 1,995 women at baseline, which decreased to 383 at 18-year follow-up.
The researchers found a significant association between BAC and freedom of an ASCVD event for participants with and without known ASCVD at baseline. In those with an ASCVD risk factor at baseline, there was a significant association between BAC and freedom of an ASCVD risk factor and a nonsignificant association in those without an ASCVD risk factor at baseline. Women with BAC were more likely to cumulatively experience ASCVD events over 18 years of follow-up (23 percent in those with BAC versus 13.9 percent in those without).
“These results suggest that the identification of BAC on routine mammography may serve as a marker for increased ASCVD risk in women over time. The presence of BAC on a mammogram should be routinely reported,” the authors wrote.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-12 08:59
Read more
- Clinical Practice Guidelines Updated for Primary Prevention of Stroke
- Sleep Apnea Could Raise Dementia Risk, Especially for Women
- Transcranial Direct Current Stimulation Safe, Effective for Tardive Dyskinesia
- FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea
- Nearly 260 Million Americans Could Be Overweight or Obese by 2050
- 1998 to 2023 Saw Decline in Triplet, Higher-Order Birth Rate
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions